Pradip Ghosh

Pradip Ghosh is a seasoned scientist with extensive experience in the development and manufacturing of radiopharmaceuticals. Currently serving as Scientist II at Radiomedix, Inc. since April 2019, Pradip focuses on cGMP manufacturing of PET and SPECT radiopharmaceuticals for cancer imaging and therapy, alongside designing targeted imaging agents for endometriosis. Prior roles include Research Scientist positions at the University of Texas Medical School at Houston, where Pradip designed multimodal imaging agents, and Proportional Technologies, Inc., specializing in PET radiopharmaceuticals production. Pradip's career began with foundational research at UT MD Anderson Cancer Center, The Methodist Hospital Research Institute, and The University of Texas Health Science Center at Houston, complemented by a Doctor of Philosophy in Bio-Organic Chemistry from Jadavpur University and postdoctoral training in Synthetic and Radiochemistry.